Risk mitigation, and the importance of assessing extractables and leachables for parenteral drug companies
Regulatory bodies need to be clearer on how pharma companies can test parenteral medication more effectively, says Novo…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
12 Feb 20
Regulatory bodies need to be clearer on how pharma companies can test parenteral medication more effectively, says Novo…
12 Feb 20
Capmatinib is a MET inhibitor intended for locally advanced (metastatic) MET exon 14 skipping (METex14) mutated NSCLC in…
11 Feb 20
RRP is a rare disease characterised by the growth of tumours in the respiratory tract, caused by a…
11 Feb 20
PEMFEXY is a pemetrexed injection ready-to-dilute formulation for locally advanced (metastatic) non-squamous non-small cell lung cancer
Four plaintiffs with mesothelioma first accused Johnson & Johnson of covering up the fact its Baby Powder talc…
10 Feb 20
In the Phase 1 clinical trial, OTX-TIC reduced intraocular pressure (IOP) in primary open angle glaucoma or ocular…
Azafaros works in rare disease treatment, developing small-molecule drugs — commonly known as pills — to reduce the…
Exscientia CEO Andrew Hopkins believes the majority of drug discovery will be done using a combination of AI…
06 Feb 20
The Phase 3 study evaluated RINVOQ for active psoriatic arthritis in adult patients who are intolerant to one…
06 Feb 20
Thermo Fisher’s Ion Torrent CarrierSeq ECS Kit consolidates multi-testing approach into a single workflow and facilitates global implementation